JomCare: A Harm Reduction Study for Men
Part of Mental health clinical trials.
This study looks at ways to reduce harm from drug use during sex (sometimes called chemsex) among cisgender men. The goal is to find better support options to keep you safe and healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be a cisgender man (assigned male at birth and identify as a man).
- You must be HIV-negative or not know your HIV status.
- In the last year, you've used drugs like crystal meth, mephedrone, GBL/GHB, or ecstasy/MDMA during sex.
- You need to own a smartphone.
- You must not be currently in drug rehab or other substance-use treatment programs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone app (DynamiCare) to help people recovering from stimulant use (methamphetamine or cocaine) stay healthy after leaving jail or prison. It also focuses on those at risk for or living with HIV.
This study looks at how to better support young men living with or at risk for HIV while also addressing substance use. You'll work with a care team that helps you stay healthy and connected to services.
This study tests a smartphone program to help young men who have sex with men stay healthy and prevent HIV. It's designed for people already getting care at certain clinics.
This study tests a program to help sexually active young adults reduce stimulant use and risky sexual behavior. It involves online coaching sessions, and you can join from home if you have a private space and video chat access.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study tests if a long-acting HIV treatment shot, called Cabenuva, works well for people who use drugs like methamphetamine or GHB during sex. It may help make treatment easier for those who find daily pills challenging.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.